Basel Medical Group Ltd [BMGL] stock prices are up 11.63% to $1.92 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The BMGL shares have gain 9.71% over the last week, with a monthly amount drifted -60.66%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Basel Medical Group Ltd [BMGL] has been fluctuating between $0.91 and $9.40 over the past year. Basel Medical Group Ltd [NASDAQ: BMGL] shares were valued at $1.92 at the most recent close of the market.
Analyzing the BMGL fundamentals
The Basel Medical Group Ltd [NASDAQ:BMGL] reported sales of 7.48M for trailing twelve months, representing a surge of 0.72%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.32 and Total Capital is 0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6667 points at the first support level, and at 1.4133 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.2267, and for the 2nd resistance point, it is at 2.5333.
Ratios To Look Out For
It’s worth pointing out that Basel Medical Group Ltd [NASDAQ:BMGL]’s Current Ratio is 1.64. On the other hand, the Quick Ratio is 1.63, and the Cash Ratio is 0.27. Considering the valuation of this stock, the price to sales ratio is 4.82, the price to book ratio is 6.76 and price to earnings (TTM) ratio is 90.14.
